Should PNPLA3 polymorphism be performed in clinical practice in patients with NAFLD to predict the risk of disease progression?
Claudia P. Oliveira
Hepatology v. 76, n. 5, p. 1246-1247, 2022Hoboken 2022
Acesso online. A biblioteca também possui exemplares impressos.
- 0
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
opi 50538 2022
opi 50457 2022
browse_callnumber
display.do?gathStatTab=true&dscnt=0&callNumberBrowseField=browse_callnumber&tabRealType=browseshelf&mode=Basic&vid=USP&rfnGrp=1&tab=usp_fisico&dstmp=1719542402674&rfnGrpCounter=1&fctV=FM&callNumber=opi+50516+2022&fctN=facet_library&vl(freeText0)=Oliveira%2C%20C&ct=display&fn=search&indx=7&recIdxs=0&elementId=0